A
$ Value
$0
Shares
42,735
Price
$0
Filed
Mar 3
Insider
Name
Grade Joel T.
Title
EVP and CFO
CIK
0001602507
Roles
Officer
Transaction Details
Transaction Date
2026-02-27
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
279,828
Footnotes
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. | Total includes shares held in the Baxter's Employee Stock Plan. | The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Filing Info
Grade Joel T.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | BAX | F | $144K |
| 2026-02-27 | BAX | A | $0 |
| 2026-02-27 | BAX | A | $0 |
| 2026-02-09 | BAX | A | $0 |
| 2026-02-09 | BAX | F | $199K |
| 2025-12-01 | BAX | F | $158K |
| 2025-09-02 | BAX | A | $0 |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |